The Global Burden of Atrial Fibrillation and Stroke: A Systematic Review of the Clinical Epidemiology of Atrial Fibrillation in Asia

Chest

Volumn 152, Issue 4, 2017, Pages 810-820

  Bai, Ying ^a,b   Wang, Yan Liang ^c   Shantsila, Alena ^a   Lip, Gregory Y H ^a,d  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c Shenzhen Salubris Pharmaceuticals Co Ltd   (China)

^d AALBORG UNIVERSITY   (Denmark)

Author keywords

Asia; atrial fibrillation; epidemiology; stroke

Indexed keywords

ANTICOAGULANT AGENT; BISPHOSPHONIC ACID DERIVATIVE; WARFARIN;

ACUTE CORONARY SYNDROME; ACUTE HEART FAILURE; ACUTE HEART INFARCTION; ARTICLE; BRAIN ISCHEMIA; CHINESE; CHRONIC KIDNEY FAILURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; INCIDENCE; JAPANESE (PEOPLE); KOREAN (PEOPLE); NEW-ONSET ATRIAL FIBRILLATION; OSTEOPOROSIS; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; RURAL AREA; SMOKING; SYSTEMATIC REVIEW; ASIA; ATRIAL FIBRILLATION; COMPLICATION; META ANALYSIS; RISK ASSESSMENT; STROKE;

ASIA; ATRIAL FIBRILLATION; HUMANS; INCIDENCE; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; STROKE;

EID: 85027677277     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1016/j.chest.2017.03.048     Document Type: Article

References (80)

1. Lip, G.Y., Brechin, C.M., Lane, D.A., The global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe. Chest 142:6 (2012), 1489–1498.
2. Greene, S.J., Fonarow, G.C., Solomon, S.D., et al. Influence of atrial fibrillation on post-discharge natriuretic peptide trajectory and clinical outcomes among patients hospitalized for heart failure: insights from the ASTRONAUT trial. Eur J Heart Fail 19:4 (2017), 552–562.
3. Jabre, P., Roger, V.L., Murad, M.H., et al. Mortality associated with atrial fibrillation in patients with myocardial infarction: a systematic review and meta-analysis. Circulation 123:15 (2011), 1587–1593.
4. Sun, G.Z., Guo, L., Wang, X.Z., et al. Prevalence of atrial fibrillation and its risk factors in rural China: a cross-sectional study. Int J Cardiol 182 (2015), 13–17.
5. Suzuki, H., Ohira, T., Takeishi, Y., et al. Increased prevalence of atrial fibrillation after the Great East Japan Earthquake: results from the Fukushima Health Management Survey. Int J Cardiol 198 (2015), 102–105.
6. Stroup, D.F., Berlin, J.A., Morton, S.C., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:15 (2000), 2008–2012.
7. Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8:5 (2010), 336–341.
8. Higgins, J.P., Thompson, S.G., Deeks, J.J., Altman, D.G., Measuring inconsistency in meta-analyses. BMJ 327:7414 (2003), 557–560.
9. Begg, C.B., Mazumdar, M., Operating characteristics of a rank correlation test for publication bias. Biometrics 50:4 (1994), 1088–1101.
10. Chen, Y., Ling, L., Su, G., et al. Effect of intermittent versus chronic calorie restriction on tumor incidence: a systematic review and meta-analysis of animal studies. Sci Rep, 6, 2016, 33739.
11. Suzuki, S., Sagara, K., Otsuka, T., et al. Usefulness of frequent supraventricular extrasystoles and a high CHADS2 score to predict first-time appearance of atrial fibrillation. Am J Cardiol 111:11 (2013), 1602–1607.
12. Rhee, C.W., Lee, J., Oh, S., Choi, N.K., Park, B.J., Use of bisphosphonate and risk of atrial fibrillation in older women with osteoporosis. Osteoporos Int 23:1 (2012), 247–254.
13. Chao, T.F., Hung, C.L., Chen, S.J., et al. The association between hyperuricemia, left atrial size and new-onset atrial fibrillation. Int J Cardiol 168:4 (2013), 4027–4032.
14. Chuang, S.Y., Wu, C.C., Hsu, P.F., et al. Hyperuricemia and incident atrial fibrillation in a normotensive elderly population in Taiwan. Nutr Metab Cardiovasc Dis 24:9 (2014), 1020–1026.
15. Guo, Y., Tian, Y., Wang, H., Si, Q., Wang, Y., Lip, G.Y., Prevalence, incidence, and lifetime risk of atrial fibrillation in China: new insights into the global burden of atrial fibrillation. Chest 147:1 (2015), 109–119.
16. Li, L.H., Sheng, C.S., Hu, B.C., et al. The prevalence, incidence, management and risks of atrial fibrillation in an elderly Chinese population: a prospective study. BMC Cardiovasc Disord, 15, 2015, 31.
17. Iguchi, Y., Kimura, K., Shibazaki, K., et al. Annual incidence of atrial fibrillation and related factors in adults. Am J Cardiol 106:8 (2010), 1129–1133.
18. Sano, F., Ohira, T., Kitamura, A., et al. Heavy alcohol consumption and risk of atrial fibrillation. The Circulatory Risk in Communities Study (CIRCS). Circ J 78:4 (2014), 955–961.
19. Watanabe, H., Tanabe, N., Yagihara, N., Watanabe, T., Aizawa, Y., Kodama, M., Association between lipid profile and risk of atrial fibrillation. Circ J 75:12 (2011), 2767–2774.
20. Kang, S.H., Choi, E.K., Han, K.D., et al. Underweight is a risk factor for atrial fibrillation: a nationwide population-based study. Int J Cardiol 215 (2016), 449–456.
21. Hingorani, P., Natekar, M., Deshmukh, S., et al. Morphological abnormalities in baseline ECGs in healthy normal volunteers participating in phase I studies. Indian J Med Res 135 (2012), 322–330.
22. Miao, H., Hong, Y., Kabinur, K., Zou, T., Palida, A., Zhou, X., Epidemiological survey of atrial fibrillation among Uygur and Han elderly people in Xinjiang Uygur autonomous region. [in Chinese] Zhonghua Liu Xing Bing Xue Za Zhi 36:10 (2015), 1065–1068.
23. Chei, C.L., Raman, P., Ching, C.K., et al. Prevalence and risk factors of atrial fibrillation in Chinese elderly: results from the Chinese Longitudinal Healthy Longevity Survey. Chin Med J (Engl) 128:18 (2015), 2426–2432.
24. Li, Y., Wu, Y.F., Chen, K.P., et al. Prevalence of atrial fibrillation in China and its risk factors. Biomed Environ Sci 26:9 (2013), 709–716.
25. Lu, W.H., Mu, H.Y., Liu, Z.Q., et al. The prevalence and distributing feature of atrial fibrillation in Xinjiang Uygur Autonomous Region Kazaks adult population. [in Chinese] Zhonghua Nei Ke Za Zhi 51:9 (2012), 674–676.
26. Modesti, P.A., Colella, A., Zhao, D., Atrial fibrillation in first generation Chinese migrants living in Europe: a proof of concept study. Int J Cardiol 215 (2016), 269–272.
27. Akao, M., Chun, Y.H., Wada, H., et al. Current status of clinical background of patients with atrial fibrillation in a community-based survey: the Fushimi AF Registry. J Cardiol 61:4 (2013), 260–266.
28. Iguchi, Y., Kimura, K., Shibazaki, K., et al. HbA1c and atrial fibrillation: a cross-sectional study in Japan. Int J Cardiol 156:2 (2012), 156–159.
29. Iwahana, H., Ishikawa, S., Ishikawa, J., et al. Atrial fibrillation is a major risk factor for stroke, especially in women: the Jichi Medical School cohort study. J Epidemiol 21:2 (2011), 95–101.
30. Ohyama, Y., Imai, M., Kurabayashi, M., Estimated glomerular filtration rate and proteinuria are separately and independently associated with the prevalence of atrial fibrillation in general population. PLoS One, 8(11), 2013, e79717.
31. Kalra, A., Pokharel, Y., Hira, R.S., et al. Cardiovascular Disease Performance Measures in the Outpatient Setting in India: insights from the American College of Cardiology's PINNACLE India Quality Improvement Program (PIQIP). J Am Heart Assoc, 4(5), 2015 pii: e001910.
32. Saggu, D.K., Sundar, G., Nair, S.G., et al. Prevalence of atrial fibrillation in an urban population in India: the Nagpur pilot study. Heart Asia 8:1 (2016), 56–59.
33. Park, H.C., Park, J.K., Choi, S.I., et al. Prevalence of atrial fibrillation and relation to echocardiographic parameters in a healthy asymptomatic rural Korean population. J Korean Med Sci 30:8 (2015), 1078–1084.
34. Albayrak, S., Ozhan, H., Aslantas, Y., et al. Predictors of major adverse cardiovascular events; results of population based MELEN study with prospective follow-up. Eur Rev Med Pharmacol Sci 19:8 (2015), 1446–1451.
35. Wong, J.S., B R, A F, I R, Fong, A.Y., Prevalence of asymptomatic atrial fibrillation in Malaysian patients with hypertension. Med J Malaysia 68:2 (2013), 141–143.
36. Sun, G., Ma, M., Ye, N., et al. Diabetes mellitus is an independent risk factor for atrial fibrillation in a general Chinese population. J Diabetes Investig 7:5 (2016), 791–796.
37. Sun, G.Z., Guo, L., Wang, J., Ye, N., Wang, X.Z., Sun, Y.X., Association between hyperuricemia and atrial fibrillation in rural China: a cross-sectional study. BMC Cardiovasc Disord, 15, 2015, 98.
38. Suzuki, S., Sagara, K., Otsuka, T., et al. Gender-specific relationship between serum uric acid level and atrial fibrillation prevalence. Circ J 76:3 (2012), 607–611.
39. Salam, A.M., AlBinali, H.A., Al-Sulaiti, E.M., Al-Mulla, A.W., Singh, R., Al Suwaidi, J., Effect of age on treatment, trends and outcome of patients hospitalized with atrial fibrillation: insights from a 20-years registry in a Middle-Eastern country (1991-2010). Aging Clin Exp Res 24:6 (2012), 682–690.
40. Garadah, T., Gabani, S., Alawi, M.A., Abu-Taleb, A., Prevalence and predisposing factors of atrial fibrillation in a multi-ethnic society: the impact of racial differences in Bahrain. Open J Cardiovasc Surg 4 (2011), 9–16.
41. Suzuki, S., Sagara, K., Otsuka, T., et al. Effects of smoking habit on the prevalence of atrial fibrillation in Japanese patients with special reference to sex differences. Circ J 77:12 (2013), 2948–2953.
42. Suzuki, S., Otsuka, T., Sagara, K., et al. Association between smoking habits and the first-time appearance of atrial fibrillation in Japanese patients: evidence from the Shinken Database. J Cardiol 66:1 (2015), 73–79.
43. Park, T.H., Ko, Y., Lee, S.J., et al. Gender differences in the age-stratified prevalence of risk factors in Korean ischemic stroke patients: a nationwide stroke registry-based cross-sectional study. Int J Stroke 9:6 (2014), 759–765.
44. Wei, Z.M., Cai, J.F., Cui, H., et al. Retrospective study on the prevalence of cardiovascular comorbidities in 4960 inpatients with chronic obstructive pulmonary disease in Beijing. [in Chinese] Zhonghua Liu Xing Bing Xue Za Zhi 32:3 (2011), 297–301.
45. Bao, B., Zhou, Y., Liu, J., Huo, Y., The 10-year stroke risk in hypertensive outpatients combined with diabetes in cardiovascular clinics of 36 tertiary hospitals in China. [in Chinese] Zhonghua Nei Ke Za Zhi 53:12 (2014), 941–946.
46. Lin, S., Wu, B., Hao, Z.L., et al. Characteristics, treatment and outcome of ischemic stroke with atrial fibrillation in a Chinese hospital-based stroke study. Cerebrovasc Dis 31:5 (2011), 419–426.
47. Wang, J., Chen, Y.C., Du, H.A., Li, X.L., Mei, X., Yin, Y.H., Prevalence and risk factors of atrial fibrillation in hospitalized patients with chronic kidney disease. [in Chinese] Zhonghua Xin Xue Guan Bing Za Zhi 41:5 (2013), 390–393.
48. Xu, Y., Guo, Y., Wang, W., et al. Association between thyroid dysfunction and incidence of atrial fibrillation in patients with stable angina pectoris. [in Chinese] Zhonghua Xin Xue Guan Bing Za Zhi 42:5 (2014), 374–378.
49. Hersi, A., Alhabib, K.F., Alsheikh-Ali, A.A., et al. Prognostic significance of prevalent and incident atrial fibrillation among patients hospitalized with acute coronary syndrome: findings from the Gulf RACE-2 Registry. Angiology 63:6 (2012), 466–471.
50. Salam, A.M., Al, B.H., Singh, R., et al. Atrial fibrillation in Middle Eastern Arab and South Asian patients hospitalized with acute myocardial infarction: experience from a 20-year registry in Qatar (1991-2010). Acta Cardiol 68:2 (2013), 173–180.
51. Sulaiman, K., Panduranga, P., Al-Zakwani, I., et al. Clinical characteristics, management, and outcomes of acute heart failure patients: observations from the Gulf Acute Heart Failure Registry (Gulf CARE). Eur J Heart Fail 17:4 (2015), 374–384.
52. Siu, C.W., Lip, G.Y., Lam, K.F., Tse, H.F., Risk of stroke and intracranial hemorrhage in 9727 Chinese with atrial fibrillation in Hong Kong. Heart Rhythm 11:8 (2014), 1401–1408.
53. Yang, Y.M., Shao, X.H., Zhu, J., et al. One-year outcomes of emergency department patients with atrial fibrillation: a prospective, multicenter registry in China. Angiology 66:8 (2015), 745–752.
54. Guo, Y., Pisters, R., Apostolakis, S., et al. Stroke risk and suboptimal thromboprophylaxis in Chinese patients with atrial fibrillation: would the novel oral anticoagulants have an impact?. Int J Cardiol 168:1 (2013), 515–522.
55. Guo, Y., Wang, H., Tian, Y., Wang, Y., Lip, G.Y., Time trends of aspirin and warfarin use on stroke and bleeding events in Chinese patients with new-onset atrial fibrillation. Chest 148:1 (2015), 62–72.
56. Chang, K.C., Wang, Y.C., Ko, P.Y., et al. Increased risk of first-ever stroke in younger patients with atrial fibrillation not recommended for antithrombotic therapy by current guidelines: a population-based study in an East Asian cohort of 22 million people. Mayo Clin Proc 89:11 (2014), 1487–1497.
57. Goto, S., Ikeda, Y., Shimada, K., et al. One-year cardiovascular event rates in Japanese outpatients with myocardial infarction, stroke, and atrial fibrillation. Results from the Japan Thrombosis Registry for Atrial Fibrillation, Coronary, or Cerebrovascular Events (J-TRACE). Circ J 75:11 (2011), 2598–2604.
58. Takabayashi, K., Hamatani, Y., Yamashita, Y., et al. Incidence of stroke or systemic embolism in paroxysmal versus sustained atrial fibrillation: the Fushimi Atrial Fibrillation Registry. Stroke 46:12 (2015), 3354–3361.
59. Chao, T.F., Liu, C.J., Chen, S.J., et al. Hyperuricemia and the risk of ischemic stroke in patients with atrial fibrillation—could it refine clinical risk stratification in AF?. Int J Cardiol 170:3 (2014), 344–349.
60. Suzuki, S., Yamashita, T., Okumura, K., et al. Incidence of ischemic stroke in Japanese patients with atrial fibrillation not receiving anticoagulation therapy—pooled analysis of the Shinken Database, J-RHYTHM Registry, and Fushimi AF Registry. Circ J 79:2 (2015), 432–438.
61. Guo, X., Zhang, Y., Xu, G., Zhou, X., Li, L., Tang, B., The clinical analysis of atrial fibrillation of 1310 in patients in Urumqi of China. [in Chinese] Zhonghua Nei Ke Za Zhi 53:5 (2014), 371–374.
62. Sun, Y., Hu, D., Chinese Investigators of GARFIELD. Chinese subgroup analysis of the global anticoagulant registry in the FIELD (GARFIELD) registry in the patients with non-valvular atrial fibrillation. [in Chinese] Zhonghua Xin Xue Guan Bing Za Zhi 42:10 (2014), 846–850.
63. Cha, M.J., Park, H.E., Lee, M.H., Cho, Y., Choi, E.K., Oh, S., Prevalence of and risk factors for silent ischemic stroke in patients with atrial fibrillation as determined by brain magnetic resonance imaging. Am J Cardiol 113:4 (2014), 655–661.
64. Ertas, F., Oylumlu, M., Akil, M.A., et al. Non-valvular atrial fibrillation in the elderly; preliminary results from the National AFTER (Atrial Fibrillation in Turkey: Epidemiologic Registry). Study. Eur Rev Med Pharmacol Sci 17:8 (2013), 1012–1016.
65. Salam, A.M., AlBinali, H.A., Al-Mulla, A.W., Singh, R., Al Suwaidi, J., Secular trends, treatments, and outcomes of Middle Eastern Arab and South Asian patients hospitalized with atrial fibrillation: insights from a 20-year registry in Qatar (1991-2010). Angiology 64:7 (2013), 498–504.
66. Choi, E.J., Lee, I.H., Je, N.K., Inadequate stroke prevention in Korean atrial fibrillation patients in the post-warfarin era. Int J Cardiol 220 (2016), 647–652.
67. Chang, S.S., Dong, J.Z., Ma, C.S., et al. Current status and time trends of oral anticoagulation use among Chinese patients with nonvalvular atrial fibrillation: The Chinese Atrial Fibrillation Registry Study. Stroke 47:7 (2016), 1803–1810.
68. Xiong, Q., Shantsila, A., Lane, D.A., et al. Sex differences in clinical characteristics and inpatient outcomes among 2442 hospitalized Chinese patients with nonvalvular atrial fibrillation: the Nanchang Atrial Fibrillation Project. Int J Cardiol 201 (2015), 195–199.
69. Zhang, J., Yang, X.A., Zhang, Y., et al. Oral anticoagulant use in atrial fibrillation-associated ischemic stroke: a retrospective, multicenter survey in northwestern China. J Stroke Cerebrovasc Dis 26 (2017), 125–131.
70. Xiang, W., Zhang, J., Liu, M., Liu, F., Feng, X., Wang, Y., Antithrombotic therapy in elderly patients with non-valvular atrial fibrillation: a pilot study. Clin Interv Aging 10 (2015), 515–519.
71. Chugh, S.S., Havmoeller, R., Narayanan, K., et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation 129:8 (2014), 837–847.
72. Go, A.S., Hylek, E.M., Phillips, K.A., et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285:18 (2001), 2370–2375.
73. European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, Camm, A.J., et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 31:19 (2010), 2369–2429.
74. Zhang, X., Zhang, S., Li, Y., et al. Association of obesity and atrial fibrillation among middle-aged and elderly Chinese. Int J Obes (Lond) 33:11 (2009), 1318–1325.
75. Zhou, Z., Hu, D., An epidemiological study on the prevalence of atrial fibrillation in the Chinese population of mainland China. J Epidemiol 18:5 (2008), 209–216.
76. Chan, Y.H., Kuo, C.T., Yeh, Y.H., et al. Thromboembolic, bleeding, and mortality risks of rivaroxaban and dabigatran in Asians with nonvalvular atrial fibrillation. J Am Coll Cardiol 68:13 (2016), 1389–1401.
77. Freedman, B., Potpara, T.S., Lip, G.Y., Stroke prevention in atrial fibrillation. Lancet 388:10046 (2016), 806–817.
78. Chen, P.C., Lip, G.Y., Yeh, G., Lin, H.J., Chien, K.L., Risk of bleeding and stroke with oral anticoagulation and antiplatelet therapy in patients with atrial fibrillation in Taiwan: a nationwide cohort study. PLoS One, 10(4), 2015, e0125257.
79. An, J., Niu, F., Lang, D.T., et al. Stroke and bleeding risk associated with antithrombotic therapy for patients with nonvalvular atrial fibrillation in clinical practice. J Am Heart Assoc, 4(7), 2015 pii: e001921.
80. Higgins JPT, Altman DG, Sterne JAC. 2011. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0 [Updated March 2011]. http://handbook.cochrane.org/. Accessed August 29, 2014.